Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-14

Clinical Trial Update: Dose Escalation Using Fiducial Markers in Image Guided Volumetric Modulated Arc Therapy to the Focal Lesion Micro Boost of Localized Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating dose escalation with fiducial markers for image-guided therapy in focal lesion micro-boost for localized prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kasr El Aini Hospital | Conditions: Prostatic Adenocarcinoma | Phase 2 | Status: COMPLETED